By inhibiting TIM-3 signaling, anti-TIM-3 shifted DCs toward an activated phenotype, increasing their uptake of tumor cell DNA and promoting secretion of Th1-attracting chemokine CXCL9. Here, HAVCR2 is linked to neoplasm.